IO Biotech, Inc.

NASDAQ:IOBT

0.829 (USD) • At close January 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 80.185100.747117.982143.193165.501110.095128.527142.59151.168170.122187.904211.53145.47754.752-3.4053.405-7.846
Short Term Investments 000000000000006.81015.692
Cash and Short Term Investments 80.185100.747117.982143.193165.501110.095128.527142.59151.168170.122187.904211.53145.47754.7523.4053.4057.846
Net Receivables 0.9641.030.9091.1270.9541.1981.0081.5331.0862.072.7892.0912.119001.50
Inventory 0000-0.9540.9291.725-1.5335.1846.5688.274-2.0914.0350.21700.3590
Other Current Assets 5.0955.8755.2372.9351.7991.7432.7314.0965.4976.7698.5558.1164.3973.74400.3710
Total Current Assets 86.244107.652124.128147.255168.254113.036132.266148.219157.751178.961199.248221.73851.99358.4963.4055.6357.846
Non-Current Assets:
Property, Plant & Equipment, Net 2.5092.6712.883.1063.1643.363.4343.2343.2522.5062.5190.15500000
Goodwill 00000000000000000
Intangible Assets 00000000000000000
Goodwill and Intangible Assets 00000000000000000
Long Term Investments 000.2680.2680.2680.2680.2680.26800.2680.2680.26800000
Tax Assets 00000000000000000
Other Non-Current Assets 1.1921.1440.8830.0890.8670.8910.8760.0841.1540.910.1360.1270.0450.038-3.4050.018-7.846
Total Non-Current Assets 3.7013.8154.0313.4634.2994.5194.5783.5864.4063.6842.9230.550.0450.038-3.4050.018-7.846
Total Assets 89.945111.467128.159150.718172.553117.555136.844151.805162.157182.645202.171222.28852.03858.53405.6530
Liabilities & Equity:
Current Liabilities:
Account Payables 5.2565.0163.843.8786.6454.4644.264.0042.3454.5412.0873.9282.1661.69600.5220
Short Term Debt 0.6941.3560.6661.311.2541.2261.1181.030.9840.8380.69000000
Tax Payables 00000000000000000
Deferred Revenue 000004.833003.037000-28.2760000
Other Current Liabilities 10.1057.3516.53710.5295.0865.1864.9795.6422.9923.1683.6536.37731.6237.25902.5280
Total Current Liabilities 16.05513.72311.04315.71712.98510.87610.35710.6766.3218.5476.4310.30533.78638.95503.050
Non-Current Liabilities:
Long Term Debt 1.3251.4721.651.8391.9762.1592.2722.2752.3471.9212.048000000
Deferred Revenue Non-Current 00000000000000000
Deferred Tax Liabilities Non-Current 00000000000000000
Other Non-Current Liabilities 000000000000.05900000
Total Non-Current Liabilities 1.3251.4721.651.8391.9762.1592.2722.2752.3471.9212.0480.05937.90637.906037.9060
Total Liabilities 17.3815.19512.69317.55614.96113.03512.62912.9518.66810.4688.47810.36471.69276.861040.9560
Equity:
Preferred Stock 00000000000062.98362.98237.90637.90622.06
Common Stock 0.0660.0660.0660.0660.0660.0290.0290.0290.0290.0290.0290.0290.0280.02800.0280
Retained Earnings -327.98-303.965-283.279-263.822-237.64-215.961-194.783-177.739-157.668-141.98-123.485-106.281-84.972-83.8780-38.4020
Accumulated Other Comprehensive Income/Loss -11-9.626-9.475-9.669-9.873-9.765-9.624-10.141-13.916-8.515-4.136-1.4890.7051.422-35.3031.961-23.531
Other Total Stockholders Equity 411.479409.797408.154406.587405.039330.217328.593326.705325.044322.643321.285319.6651.60283.5950-36.7960
Total Shareholders Equity 72.56596.272115.466133.162157.592104.52124.215138.854153.489172.177193.693211.924-19.654-18.3272.603-35.303-1.471
Total Equity 72.56596.272115.466133.162157.592104.52124.215138.854153.489172.177193.693211.924-19.654-18.3272.603-35.303-1.471
Total Liabilities & Shareholders Equity 89.945111.467128.159150.718172.553117.555136.844151.805162.157182.645202.171222.28852.03858.5342.6035.653-1.471